Persistent atrial fibrillation with left atrial low-voltage area: who benefit from additional modification?

Europace · 2025 · PMC12076150 · PMID 40327545

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

9 , 30 The STABLE-SR trial found significant benefits in PeAF patients, but the results of the subsequent STABLE-SR–II trial failed to reach statistical significance. 21 , 31 These trials reconfirmed CPVI as the cornerstone for AF ablation in patients without LVAs, while leaving additional LVA modification in patients with LVAs controversial.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.